The Misuse of Drugs (Amendment) Regulations 2003

Made5th June 2003

Laid before Parliament5th June 2003

Coming into force1st July 2003

In pursuance of sections 10 and 31 of the Misuse of Drugs Act 19711, after consultation with the Advisory Council on the Misuse of Drugs, the Secretary of State hereby makes the following Regulations:

1

These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2003 and shall come into force on 1st July 2003.

2

1

The Misuse of Drugs Regulations 20012, shall be amended as follows.

2

In paragraph 1 of Schedule 2 there shall be inserted—

a

after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and

b

after “Racemorphan”, “Remifentanil”.

3

In paragraph 1, Part 1 of Schedule 4 there shall be inserted—

a

after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and

b

after “N-Ethylamphetamine”, “Zolpidem”.

4

In paragraph 1, Part II of Schedule 4 there shall be inserted—

a

before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17 diol”; and

b

after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione” and “19-Nor-5-Androstene-3, 17 diol”.

Bob AinsworthParliamentary Under-Secretary of StateHome Office5th June 2003

(This note is not part of the Regulations)

These Regulations amend the Misuse of Drugs Regulations 2001 by adding two substances to paragraph 1 of Schedule 2 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27) two substances to Part I of Schedule 4 (controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) and four substances to Part II of Schedule 4 (controlled drugs excepted from the prohibition on possession when in the form of a medicinal product; excluded from the application of offences arising from the prohibition on importation and exportation when imported or exported in the form of a medicinal product by any person for administration to himself; and subject to the requirements of regulations 22, 23, 26 and 27).